An eight-month clinical study of LA-2575 30.0 mg: a new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer
Oliver Sartor, Martin K Dineen, Ramon Perez-Marreno, Franklin M Chu, Graham J Carron, Robert C TylerVolume:
62
Year:
2003
Language:
english
DOI:
10.1016/s0090-4295(03)00330-3
File:
PDF, 114 KB
english, 2003